Cowen Raises MedReleaf (LEAF) Price Target to C$36.00
A number of other equities analysts have also weighed in on the stock. Canaccord Genuity lifted their price objective on shares of MedReleaf from C$15.00 to C$20.00 in a research report on Tuesday, November 14th. Eight Capital lifted their price objective on shares of MedReleaf from C$13.00 to C$20.00 and gave the company a buy rating in a research report on Wednesday, November 15th.
MedReleaf (TSE LEAF) opened at C$26.40 on Monday. The company has a market cap of $2,500.00 and a price-to-earnings ratio of 1,320.00. MedReleaf has a 1-year low of C$6.81 and a 1-year high of C$31.25.
Receive News & Ratings for MedReleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedReleaf and related companies with MarketBeat.com's FREE daily email newsletter.